Raritan Valley Medical Group is categorized under Primary Care Centers in Hillsborough, NJ and active since 2009.
Raritan Valley Medical Group was established in 2009, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Primary Care Centers business, which does work in the B2C market, and is classified as a Primary Care Centers, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Thomas Shaffrey at the company’s single location by writing to 313 Courtyard Drive, Hillsborough, New Jersey NJ 08844 or by phoning (908) 595-1292. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Raritan Valley Medical Group |
| Contact Person: | Thomas Shaffrey |
| Address: | 313 Courtyard Drive, Hillsborough, New Jersey 08844 |
| Phone Number: | (908) 595-1292 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Primary Care Centers |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Raritan Valley Medical Group was started in 2009 to provide professional Primary Care Centers under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Thomas Shaffrey for inquiries that concern Raritan Valley Medical Group by calling the company number (908) 595-1292, as your correspondence is most welcome. Additionally, the physical location of the single location of Raritan Valley Medical Group can be found at the coordinates 40.549589,-74.612633 as well as the street address 313 Courtyard Drive in Hillsborough, New Jersey 08844.
For its online presence, you may visit Raritan Valley Medical Group’s website at and engage with its social media outlets through on Twitter and on Facebook.